(AP)—The Food and Drug Administration has approved a new long-acting inhaler drug from Boehringer Ingelheim to treat people with chronic lung disease.
16 hours ago
not rated yet | 0
Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective.
Jul 27, 2014
4.7 / 5 (3) | 0